말초동맥질환의 진단과 치료

키워드

참고문헌 (21)

1. Belch JJ, "Critical issues in peripheral arterial disease detection and management: a call to action", Arch Intern Med, 163(8), pp.884~892 (2003)
2. Murabito JM, "Prognosis after the onset of coronary heart disease. An investigation of differences in outcome between the sexes according to initial coronary disease presentation", Circulation, 88(6), pp.2548~2555 (1993)
3. Murabito JM, "Temporal trends in the incidence of intermittent claudication from 1950 to 1999", Am J Epidemiol, 162(5), pp.430~437 (2005)
4. Dormandy JA, "Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society consensus (TASC)", J Vasc Surg, 31, pp.117~296 (2000)
5. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, "Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)", JAMA, 285(19), pp.2486~2497 (2001)
6. Mancia G, "Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)", J Hypertens, 25(6), pp.1105~1187 (2007)
7. Hirsch AT, "Peripheral arterial disease detection, awareness, and treatment in primary care", JAMA, 286, pp.1317~1324 (2001)
8. Criqui MH, "Barrett-Connor E, Klauber MR, Gabriel S, Goodman D. The prevalence of peripheral arterial disease in a defined population", Circulation, 71(3), pp.510~515 (1985)
9. Weitz JI, "Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review", Circulation, 94, pp.3026~3049 (1996)
10. Fowkes FG, "Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study", Am J Epidemiol, 135, pp.331~340 (1992)
11. Price JF, "Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery Study", Eur Heart J, 20(5), pp.344~353 (1999)
12. McDaniel MD, "Basic data related to the natural history of intermittent claudication", Ann Vasc Surg, 3, pp.273~277 (1989)
13. Hirsch AT, "ACC", AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery, AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients with Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; Transatlantic Inter- Society Consensus; and Vascular Disease Foundation, pp.Circulation, 2006[DOI]
14. American Diabetes Association, "Peripheral arterial disease in people with diabetes", Diabetes Care, 26, pp.3333~3341 (2003)
15. Leng GC, "The Edinburgh Claudication Questionnaire: an improved version of the WHO", Rose Questionnaire for use in epidemiologic surveys, 1992, pp.45, 1101~1109
16. McGee SR, "Physical examination and chronic lower-extremity ischemia: a critical review", Arch Intern Med, 158, pp.1357~1364 (1998)
17. Lijmer JG, "ROC analysis of noninvasive tests for peripheral arterial disease", Ultrasound Med Biol, 22, pp.391~398 (1996)
18. Heart Protection Study Collaborative Group, "MRC", BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomized placebo- controlled trial, 2002, pp.360, 7~22
19. Pedersen TR, "Effects of simvastatin on ischemic signs and symptoms in the Scandinavian simvastatin survival study (4S)", Am J Cardiol, 81, pp.333~335 (1998)
20. Ostergren J, "Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease", Eur Heart J, 25, pp.17~24 (2004)
21. "The Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients", BMJ, 324, pp.71~86 (2002)

관련 논문AI추천